NAUT
NASDAQ · Life Sciences Tools & Services
Nautilus Biotechnology Inc
$3.48
-0.30 (-7.94%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+663.2% upside
Low Target
$24.26
Average Target
$26.56
High Target
$41.87
Current Price
$3.48
Current
$3.48
$3.48
Target
$26.56
$26.56
$24.26
$26.56 avg
$41.87
Scenario Analysis
Bear Case
$24.26
597.1%
Low target
Base Case
$26.56
+663.2%
Avg target
Bull Case
$41.87
+1,103.2%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$3.08
13.0% from high
52-Week Low
$0.62
+461.3% from low
Target vs 52W High
$26.56
+762.3% vs high
Peer Consensus — Life Sciences Tools & Services
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| TMO | Strong Buy | 33 | 88% | $369.21 | -25.3% |
| DHR | Strong Buy | 30 | 87% | $158.11 | -17.1% |
| A | Buy | 29 | 72% | $64.69 | -43.5% |
| IQV | Strong Buy | 30 | 80% | $82.96 | -51.9% |
| MTD | Hold | 21 | 43% | $170.43 | -86.6% |
| ILMN | Hold | 28 | 54% | $169.36 | +33.7% |
| WAT | Buy | 28 | 57% | $189.60 | -36.8% |
| WST | Strong Buy | 23 | 78% | $136.24 | -46.1% |